These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7004342)

  • 1. Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
    Nishi T; Tsuchiya K
    Antimicrob Agents Chemother; 1980 Oct; 18(4):549-56. PubMed ID: 7004342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of in vitro antibacterial activities of cefotiam and cefazolin to their therapeutic effects on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
    Nishi T; Nakao M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Feb; 34(2):231-9. PubMed ID: 6271719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo morphological response of Klebsiella pneumoniae to cefotiam and cefazolin.
    Nakao M; Nishi T; Tsuchiya K
    Antimicrob Agents Chemother; 1981 May; 19(5):901-10. PubMed ID: 6271051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; van den Berg JC; Michel MF
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1042-50. PubMed ID: 6297384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; van den Berg JC; Vree TB; Baars AM; Michel MF
    Antimicrob Agents Chemother; 1985 Nov; 28(5):654-9. PubMed ID: 3911879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of mathematical model to experimental chemotherapy of fatal murine pneumonia.
    Hishikawa T; Kusunoki T; Tsuchiya K; Uzuka Y; Sakamoto T; Nagatake T; Matsumoto K
    Antimicrob Agents Chemother; 1990 Feb; 34(2):326-31. PubMed ID: 2183718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activities of cefotiam and cefazolin against urinary tract infections with Proteus mirabilis in mice.
    Iwahi T; Tsuchiya K
    Antimicrob Agents Chemother; 1980 Aug; 18(2):257-63. PubMed ID: 7004338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ceftazidime in experimental Klebsiella pneumoniae pneumonia: comparison with other antibiotics and measurement of its penetration into respiratory tissues and secretions.
    McColm AA; Shelley E; Ryan DM; Acred P
    J Antimicrob Chemother; 1986 Nov; 18(5):599-608. PubMed ID: 3542926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of mathematical model to multiple-dose experimental chemotherapy for fatal murine pneumonia.
    Hishikawa T; Kusunoki T; Tsuchiya K; Uzuka Y; Sakamoto T; Nagatake T; Matsumoto K
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1066-9. PubMed ID: 1929244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of protein binding in serum on therapeutic efficacy of cephem antibiotics.
    Tawara S; Matsumoto S; Kamimura T; Goto S
    Antimicrob Agents Chemother; 1992 Jan; 36(1):17-24. PubMed ID: 1590685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-spectrum cephalosporin compared to cefazolin for treatment of Klebsiella pneumoniae-caused liver abscess.
    Cheng HP; Siu LK; Chang FY
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2088-92. PubMed ID: 12821451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental respiratory tract infection with Klebsiella pneumoniae DT-S in mice: chemotherapy with kanamycin.
    Nishi T; Tsuchiya K
    Antimicrob Agents Chemother; 1980 Mar; 17(3):494-505. PubMed ID: 6999983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the so-called basic cephalosporins using the serum bactericidal test].
    Milatovic D; Voss A; Machka K; Braveny I
    Med Klin (Munich); 1992 Feb; 87(2):58-62. PubMed ID: 1542283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of revised susceptibility breakpoints on bacteremia of Klebsiella pneumoniae: Minimum inhibitory concentration of cefazolin and clinical outcomes.
    Chuang CH; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2016 Oct; 49(5):679-684. PubMed ID: 25442869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of cefpirome (HR 810) and other cephalosporins on experimentally induced pneumonia in mice.
    Klesel N; Isert D; Limbert M; Seibert G; Winkler I; Schrinner E
    J Antibiot (Tokyo); 1986 Jul; 39(7):971-7. PubMed ID: 3531131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanamycin.
    Berendt RF; Long GG; Walker JS
    Antimicrob Agents Chemother; 1975 Nov; 8(5):585-90. PubMed ID: 1108778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceforanide and cefazolin therapy of pneumonia: comparative clinical trial.
    Wallace RJ; Martin RR; Quinones FJ; Greenberg SB
    Antimicrob Agents Chemother; 1981 Nov; 20(5):648-52. PubMed ID: 7034641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhalation therapy of antibiotics].
    Noguchi Y; Taguchi M; Takasugi M; Sakamoto T; Matsumoto K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1432-5. PubMed ID: 2290226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.
    Leggett JE; Fantin B; Ebert S; Totsuka K; Vogelman B; Calame W; Mattie H; Craig WA
    J Infect Dis; 1989 Feb; 159(2):281-92. PubMed ID: 2644371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
    Pichardo C; Rodríguez-Martínez JM; Pachón-Ibañez ME; Conejo C; Ibáñez-Martínez J; Martínez-Martínez L; Pachón J; Pascual A
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3311-6. PubMed ID: 16048941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.